Stay updated on Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page now displays Revision: v3.7.0 in place of Revision: v3.6.6, indicating an internal update to the page's revision history rather than changing study information shown to users.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page’s Revision label changed from v3.6.5 to v3.6.6, indicating a small update to the page’s documentation/versioning rather than to the study details.SummaryDifference0.0%

- Check23 days agoChange DetectedA new line '2016 ( U.S. NIH Grant/Contract )' was added to the study's funding/identification information. This addition documents NIH support for the trial within the record.SummaryDifference0.0%

- Check30 days agoChange DetectedSite-wide status banners indicating an outage and intermittent delays have been removed. The page now presents only the study details without the preceding service-status notices.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded a sitewide outage warning banner with a message about intermittent delays and updated the revision to v3.6.5 (replacing v3.6.4).SummaryDifference0.1%

- Check59 days agoChange DetectedThe revision label on the page updates from v3.6.3 to v3.6.4, indicating a new minor version of the page/document.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.